Current Employment Position(s)

Partner

Lawyer Overview

Dr. Rahul Pathak has extensive experience representing companies in areas of patent law related to chemistry and biochemistry. Dr. Pathak advises clients in the fields of pharmaceuticals, biotechnology, biofuels, and fuel additives among others. Dr. Pathak's representative clients include start-up companies, established companies, academic institutions, and investment firms.

Dr. Pathak has a strong background in patent procurement and portfolio management, patent opinions, and ex parte and inter partes reexamination. Over the past 10 years, Dr. Pathak has advised clients on managing global patent portfolios for marketed pharmaceuticals, developing patent portfolios for new chemical entities, conducting intellectual property due diligence for private and public investments in pharmaceutical and biotechnology companies, and developing a patent portfolio of biofuels.

Dr. Pathak has extensive experience with small molecule pharmaceuticals, peptide pharmaceuticals, polypeptide pharmaceuticals, nucleic acid diagnostics, polypeptide biochemistry, structural biology, and molecular biology.

In 2008, Dr. Pathak was listed among the Daily Journal's "Leading Portfolio Managers, Patent Prosecutors and Litigators."

Prior to joining Jones Day, Dr. Pathak was an associate at Pennie & Edmonds LLP.

Areas of Practice

• Intellectual Property
• Patent Prosecution
• Life Sciences
• Pharmaceuticals

Representative Cases

• Issuance of Shares by Ambrx, Inc.
• Patent Prosecution
• Patent Prosecution

West Practice Categories

Copyrights, Intellectual Property Law, International Intellectual Property, Patents, Technology Licensing, Trade Dress, Trade Secrets, Trademarks

Bar Admissions

• California

Education

• U of California - Berkeley

Published Works

• Biofuels: A (Carbon) Balanced Act, The Daily Transcript, Vol. 123, No. 223, 2008
• A dual affinity tag on the 64-kDa Nlt1p subunit allows the rapid characterization of mutant yeast oligosaccharyl transferase complexes, coauthor, Arch Biochem Biophys. 338(1):1-6, 1997
• Sulfhydryl modification of the yeast Wbp1p inhibits oligosaccharyl transferase activity, coauthor, FEBS Lett. 362(2):229-34, 1995
• The essential yeast NLT1 gene encodes the 64 kDa glycoprotein subunit of the oligosaccharyl transferase, coauthor, FEBS Lett. 362(2):229-34, 1995

Address

1755 Embarcadero Road
Palo Alto, CA 94303

Phones

1.650.739.3983 (Business Phone)

Faxes

1.650.739.3900 (Business Fax)

Emails

Contact Us (Business Email)

Websites

http://www.jonesday.com